SigTuple’s AI100 with Shonit receives USFDA 510(k) clearance
SigTuple’s AI100 with Shonit is the premier solution for AI assisted digital pathology
SigTuple’s AI100 with Shonit is the premier solution for AI assisted digital pathology
Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe
Post-acquisition of the balance 25% outstanding shares will result into Sun Pharma de México, S.A. de C.V. becoming a wholly-owned subsidiary of the company.
The AGE1.CR.pIX cell line's versatility allows it to support a wide range of viruses and vaccine types
The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing
Commenced operations in flood-affected Himachal Pradesh
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
The campus in Genome Valley will provide services in discovery chemistry & discovery biology, safety toxicology, bioanalytical services and formulation development to global pharmaceutical companies
The companies will work with investigators to share the results with the scientific community
Prior to this, Jim held leadership positions at several companies, including Centrient Pharmaceuticals, Leo Pharmaceuticals, Sandoz, Xellia, and GSK
Subscribe To Our Newsletter & Stay Updated